I. Paul Singh, MD; and Dagny Zhu, MD
Show Description +
Dagny Zhu, MD, and I. Paul Singh, MD, discuss the role of YAG vitreolysis for treating symptomatic vitreous floaters. Dr. Zhu shares that she started experimenting with YAG vitreolysis to treat patients with significant vitreous opacities following cataract surgery.
Posted: 6/02/2026
I. Paul Singh, MD; and Zarmeena Vendal, MD
I. Paul Singh, MD; and Eric Donnenfeld, MD
I. Paul Singh, MD; and Christine M. Funke, MD
I. Paul Singh, MD; and Christine M. Funke, MD
I. Paul Singh, MD; and William F. Wiley, MD
I. Paul Singh, MD; and Marjan Farid, MD
I. Paul Singh, MD; and Cathleen M. McCabe, MD
I. Paul Singh, MD; and John Doane, MD
I. Paul Singh, MD; and Damien F. Goldberg, MD
I. Paul Singh, MD; and Darrell E. White, MD
I. Paul Singh, MD; and Denise M. Visco, MD, MBA
I. Paul Singh, MD; and Steven R. Sarkisian Jr, MD
I. Paul Singh, MD; and Carl D. Regillo, MD
I. Paul Singh, MD; and Carl D. Regillo, MD
I. Paul Singh, MD; and Julie Schallhorn, MD
I. Paul Singh, MD; and Sahar Bedrood, MD, PhD
I. Paul Singh, MD; and Jason Bacharach, MD
I. Paul Singh, MD; and Brandon D. Ayres, MD
I. Paul Singh, MD; and Arsham Sheybani, MD
I. Paul Singh, MD; and Robert J. Noecker, MD, MBA
I. Paul Singh, MD; and Mitchell A. Jackson, MD
I. Paul Singh, MD; and David Eichenbaum, MD
I. Paul Singh, MD; and Joe Panarelli, MD
I. Paul Singh, MD; and Gary Wörtz, MD
I. Paul Singh, MD; and Daniel S. Durrie, MD
I. Paul Singh, MD; and Karl G. Stonecipher, MD
I. Paul Singh, MD; and John A. Hovanesian, MD, FACS
I. Paul Singh, MD; and Christopher E. Starr, MD
I. Paul Singh, MD; and Nandini Venkateswaran, MD
I. Paul Singh, MD; and Blake K. Williamson, MD, MPH, MS
I. Paul Singh, MD; and Charles C. Wykoff, MD, PhD, FACS
I. Paul Singh, MD; and Marguerite McDonald, MD, FACS
I. Paul Singh, MD; and Ranya Habash, MD
I. Paul Singh, MD; and J. Morgan Micheletti, MD
I. Paul Singh, MD; and Cathleen M. McCabe, MD
I. Paul Singh, MD; and Laura M. Periman, MD
I. Paul Singh, MD; and Leonard K. Seibold, MD
I. Paul Singh, MD; and Darrell E. White, MD
I. Paul Singh, MD; and Darrell E. White, MD
I. Paul Singh, MD; and Sila Bal, MD, MPH
I. Paul Singh, MD; and Arjan Hura, MD
I. Paul Singh, MD; and Dagny Zhu, MD
I. Paul Singh, MD; and Dagny Zhu, MD
I. Paul Singh, MD; and William F. Wiley, MD
I. Paul Singh, MD; and Steve Charles, MD, FACS, FICS
I. Paul Singh, MD; and Mark J. Gallardo, MD
I. Paul Singh, MD; and Ralph Chu, MD
I. Paul Singh, MD; and Mark Lobanoff, MD
I. Paul Singh, MD; and Sahar Bedrood, MD, PhD
I. Paul Singh, MD; and Brandon D. Ayres, MD
I. Paul Singh, MD; and Nathan M. Radcliffe, MD
I. Paul Singh, MD; and James A. Katz, MD
I. Paul Singh, MD; and Mark J. Gallardo, MD
I. Paul Singh, MD
I. Paul Singh, MD; and Dagny Zhu, MD
Dagny Zhu, MD, and I. Paul Singh, MD, discuss the role of YAG vitreolysis for treating symptomatic vitreous floaters. Dr. Zhu shares that she started experimenting with YAG vitreolysis to treat patients with significant vitreous opacities following cataract surgery.
Posted: 6/02/2026
Michael Patterson, DO
Kostas Boboridis, MD, PhD, FEBO
Dr Suresh K Pandey, Vidushi Sharma, MD, FRCS
Please log in to leave a comment.
Comments
Just Now
Christopher Wood
3 weeks ago
Thanks for providing a rational floater management presentation! I would love to see a presentation with a retinologist for a spectrum of care practice pattern from initial PVD management to laser vitreolysis and finally floaterectomy vitrectomy as needed. It's far to late for the majority of our colleagues to be instilling fear in their patients regarding management of visually significant vitreous floaters.